Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation

BACKGROUND: Chromogenic anti-factor Xa activity (AXA) assay is used to measure the pharmacodynamics of factor Xa inhibitors, including edoxaban. Although AXA concentrations in patients with non-valvular atrial fibrillation using edoxaban have been reported, the impact of renal function on AXA concen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ono, Ryohei, Nishimura, Kazutaka, Takahashi, Hidehisa, Hori, Yasuhiko, Fukushima, Kenichi, Kobayashi, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700531/
https://www.ncbi.nlm.nih.gov/pubmed/36104542
http://dx.doi.org/10.1007/s40268-022-00403-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700531/
https://www.ncbi.nlm.nih.gov/pubmed/36104542
http://dx.doi.org/10.1007/s40268-022-00403-5

Ejemplares similares